Please assess the completion status of the following clinical trial:

Trial Title: Energy Balance Following Islet Transplantation

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Islet transplant and pump therapy~  * Male or Female~ * Age 18 or over~ * Type 1 diabetes.~ * On waiting list for islet transplantation or insulin pump therapy.~ * Normal renal function (GFR \>60).~ * Normal thyroid function (those on thyroxine may be included provided their thyroid function tests are normal).~ * Able to understand and undertake the study procedures.~ * Able to give signed informed consent.~* Healthy controls~  * Male or Female.~ * Age 18 or over.~ * Glucose tolerant.~ * Normal renal function (GFR \>60).~ * Normal thyroid function (those on thyroxine may be included provided their thyroid function tests are normal).~ * Willingness to understand and undertake study procedures.~ * Able to give signed informed consent.~Exclusion Criteria:~* Islet transplant and pump therapy~  * Age less than 18~ * Impaired renal function (GFR \<60)~ * Impaired thyroid function despite therapy~ * Unable to adhere to the study timetable.~ * Unwilling to give informed consent.~* Healthy Controls~  * Age less than 18~ * Impaired glucose-tolerance~ * Impaired thyroid function~ * Impaired renal function (GFR \<60)~ * Unable to adhere to the study timetable.~ * Unwilling to give informed consent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- Islet Transplant Patients (Type: ACTIVE_COMPARATOR): Patients with Type 1 Diabetes who are on the waiting list to undergo an islet transplant.
- Insulin Pump Therapy Patients (Type: ACTIVE_COMPARATOR): Patients with Type 1 Diabetes waiting to start on an Insulin Pump.
- Healthy Volunteers (Type: OTHER): Participants with no Diabetes.

Based on this trial design, predict the completion outcome and termination type (if applicable).